A systematic review of Long COVID identifies symptom clusters, highlighting fatigue and proposing a management framework for ...

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally. Effective management ...

Background: The COVID-19 pandemic has transitioned into an endemic phase with heterogeneous resurgences. Despite widespread vaccination and public health measures, the interplay of viral evolution, ...

Dominion Energy says its upcoming $11-a-month rate hike is driven by grid upgrades and inflation — not Virginia’s rapidly growing data-center industry. Critics note that Virginia hosts one of the ...

Born out of an internal hackathon, Amazon’s Autonomous Threat Analysis system uses a variety of specialized AI agents to detect weaknesses and propose fixes to the company’s platforms. ATA was born ...

A new study shows children and young people face long-lasting and higher risks of rare heart and inflammatory complications after COVID-19 infection, compared to before or without an infection.

Changes in the vaccine advisory process in the United States have disrupted immunization guidance, which reinforces the need for independent evidence review to inform decisions regarding immunization ...

A biennial prize fund to promote thought leadership around the big questions affecting health economics. OHE’s educational mission is to support, sustain, and enhance the discipline of health ...

Have you ever stared at a massive spreadsheet, unsure how to turn that sea of numbers into something meaningful? You’re not alone. Despite Excel being one of the most widely used tools in the world, ...

In this tutorial, we demonstrate how to build an advanced yet accessible Bioinformatics AI Agent using Biopython and popular Python libraries, designed to run seamlessly in Google Colab. By combining ...

This brief was originally published in December 2020 and updated in July 2025. In 2023, at a time when maternal mortality was declining worldwide, the World Health Organization (WHO) declared that the ...

Attractive safety profile demonstrated across all dosing cohorts and routes of administration (IV, SC, and IM); all reported adverse events (AEs) deemed unrelated or classified as mild to moderate and ...